Pathology and autoimmunity

Current Opinion in Gastroenterology

Volumn 14, Issue SUPPL. 1, 1998, Pages

  Kirchner, Thomas ^a   Faller, Gerhard ^a   Price, Ashley ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Northwick Park and St Mark's Hospitals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE;

ATROPHY; AUTOIMMUNITY; BLOOD GROUP LEWIS SYSTEM; DISEASE PREDISPOSITION; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MOLECULAR MIMICRY; PATHOLOGY; PEPTIC ULCER; PHENOTYPE; PROGNOSIS; REVIEW; RISK; STOMACH ANTRUM; STOMACH PARIETAL CELL; TOPOGRAPHY;

EID: 0031718274     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199801031-00008     Document Type: Review

References (46)

1. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997;29:671-678.
2. Schultze V, Hackelsberger A, Günther T, Miehlke S, Roessner A, Malfertheiner P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol 1998;33:137-142.
3. Meining A, Stolte M, Hatz R, Lehn N, Miehlke S, Morgner A, Bayerdörffer E. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997;431:11-15.
4. Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-314. This study defines a gastric carcinoma risk index for H. pylori gastritis and shows its clinical relevance.
5. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997; 11 (suppl. 1):71-88.
6. McColl KEL. Helicobacter pylori and acid secretion: where are we now? Eur J Gastroenterol Hepatol 1997,9:333-335.
7. Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology 1997;112:2108-2110. This study proposed that there are three histological phenotypes of H. pylori gastritis with clinical and prognostic impacts.
8. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24. An excellent study showing the diagnostic criteria and the characteristics of a special phenotype of hypochlorhydric body-predominant H. pylori gastritis.
9. Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997;2:57-64.
10. Tucci A, Biasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997;336:957-958. A scientific letter about a prospective study indicating a possible reversibility of fundic atrophy at 12 months after the successful eradication of H. pylori.
11. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Porro GB. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer. Am J Gastroenterol 1997;92:1843-1848.
12. Van der Hulst RWM, van der Ende A, Dekker FW, Ten Kate FJW, Weel JFL, Keller JJ et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113:25-30. A prospective 1 year follow-up study showing no change of atrophy and intestinal metaplasia after the successful eradication of H. pylori, irrespective of the CagA status.
13. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997;32:664-668.
14. Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997;113:51-55.
15. Dixon MF. Commentary: role of Helicobacter pylori on gastric mucosal damage, gastric cancer, and gastric MALT lymphoma. Gastroenterology 1997; 113:65-66.
16. Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A et al. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol 1998;93:375-379.
17. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997;41:740-747. A prospective study demonstrating a marked increase of body gastritis in H. pylori-infected patients during long-term treatment with a proton pump inhibitor.
18. Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y et al. The role of the HLA DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998,82:1013-1018. This study shows that a host genetic factor can be correlated with resistance to H. pylori-associated atrophic gastritis and intestinal type gastric adenocarcinoma.
19. Faller G, Steininger H, Kränzlein J, Maul H, Kerkau T, Hensen J et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997;41:619-623. This is the first comprehensive study of the significant correlations of anti-canalicular serum autoantibodies with histological as well as functional parameters of atrophy in H. pylori gastritis.
20. Faller G, Winter M, Steininger H, Konturek P, Konturek SJ, Kirchner T. Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer dyspesia. Scand J Gastroenterol 1998;33:276-282. This is the first study showing a correlation between the presence of anti-canalicular serum autoantibodies and a decrease in acid secretion in H. pylori infection.
21. Faller G, Winter M, Steininger H, Lehn N, Meining A, Bayerdörffer E, Kirchner Th. Decrease of antigastric autoantibodies after cure of H. pylori infection. Gut 1997, 41 (suppl. 1):A61-A62.
22. Steininger H, Faller G, Dewald E, Brabletz T, Jung A. Rate of apoptosis in chronic gastritis and its correlation with antigastric autoantibodies. Virchows Arch 1998;433:13-18. Using the terminal desoxynucleotidyl-transferase mediated dUTP-biotin nick end labelling (TUNEL) method, this study showed a correlation between anticanalicular autoantibodies and increased apoptosis in the gastric corpus glands, indicating that body atrophy could result from autoimmunity-mediated cell death.
23. + ATPase is a major autoantigen in chronic H. pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340-342. Characterization of the anticanalicular autoantibodies by means of Western blotting and immunoblotting reveals that approximately 50% of autoantibodies react with the peptide part of the a and b subunit of the gastric proton pump. This autoreactivity shows a strong correlation with body mucosa atrophy. The nature of the corresponding antigen of the other 50% remains unclear.
24. Saxena V, Asante M, Mendall MA, Neira N, Zaitoun AM, Northfield TC. Gastric parietal cell (GPC) antibodies are associated with an altered distribution of Helicobacter pylori and increased body atrophy. Gut 1998;42 (suppl. 1):A79.
25. Barrio R, Roldán MB, Alonso M, Cantón R, Camarero C. Helicobacter pylori infection with parietal cell antibodies in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr Endocrinol Metab 1997; 10:511-515.
26. Appelmelk BJ, Faller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CMJE. Bugs on trial: the case of Helicobacter pylori and gastric autoimmunity. Immunol Today 1998;19:296-299. This review summarizes the present knowledge on H. pylori-associated antigastric autoimmunity and speculates on the pathogenic link between H. pylori and classical autoimmune gastritis.
27. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 1997;5:70-73.
28. Martin SL, Edbrooke MR, Hodgman TC, van den Eijnden DH, Bird MI. Lewis X biosynthesis in Helicobacter pylori. J Biol Chem 1997;272:21349-21356.
29. Monteiro MA, Chan KHN, Rasko DA, Taylor DE, Zheng PY, Appelmelk BJ et al. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J Biol Chem 1998;273:11533-11543. Structural studies show type 1 and type 2 Lewis antigens in the LPS of H. pylori.
30. Cróinin TÓ, Clyne M, Drumm B. Molecular mimicry of ferret gastric epithelial blood group antigen A by Helicobacter mustelae. Gastroenterology 1998; 114:690-696.
31. Ko GH, Park HB, Shin MK, Park CK, Lee JH, Youn HS et al. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter 1997;2:210-215.
32. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth H-P, Blaser MJ et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A 1998;95:3925-3930.
33. +-ATPase and intrinsic factor. Gut 1997;41 (suppl. 1):A17.
34. Amano K-I, Hayashi S, Kubota T, Fujii N, Yokota S-I. Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin Diagn Lab Immunol 1997;4:540-544.
35. Wirth H-P, Yang M, Peek RM, Tham KT, Blaser MJ. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997; 113:1091-1098.
36. Wirth H-P, Yang M, Peek RM, Tham KT, Blaser MJ. H. pylori Lewis expression: relationship to host Lewis phenotype, antibody response to Lewis antigens, and gastric histopathology. Gut 1997; 41 (suppl. 1):A61.
37. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997;100:759-762.
38. Appelmelk BJ, Shiberu B, Trinks C, Tapsi N, Zheng PY, Verboom T et al. Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun 1998; 66:70-76.
39. Faller G, Steininger H, Appelmelk B, Kirchner T. Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J Clin Pathol 1998;51:244-245. This study shows that anticanalicular autoantibodies can not be absorbed to H. pylon, indicating that other pathomechanisms than molecular mimicry lead to H. pyloriassociated antigastric autoimmunity.
40. Czinn SJ, Nedrud JG. Immunopathology of Helicobacter pylori infection and disease. Springer Semin Immunopathol 1997;18:495-513. This study precisely reviews the immune response in H. pylori gastritis.
41. Ernst PB, Crowe SE, Reyes VE. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 1997;113:35-42.
42. Kelleher D, Windle H, Fan X. Human immune responses to Helicobacter pylori infection. In: Pathogenesis and host response in Helicobacter pylori infections. Moran AP, O'Morain CA (editors). Englewood, NJ: Normed Verlag; 1997. pp. 148-157.
43. Kirchner T, Steininger H, Faller G. Immunopathology of Helicobacter pylori gastritis. Digestion 1997;58 (suppl. 1):14-16.
44. Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 1997; 65:4229-4235.
45. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-492. This study reported that most T cells in H. pylori gastritis are Th-1 cells.
46. Ye G, Barrera C, Fan X, Gourley WK, Crowe SE, Ernst PB, Reyes VE. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells. J Clin Invest 1997;99:1628-1636. The expression of co-stimulatory molecules on gastric epithelial cells was shown to mediate T-cell activation in H. pylori gastritis.